| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $227.8M | +7.8% | +53.6% |
| R&D Expense | $12.3M | -25.6% | +21.5% |
| SG&A Expense | $76.7M | -6.3% | -3.1% |
| Operating Income | $36.2M | +160.9% | +276.6% |
| Interest Expense | $8.3M | +0.7% | +24.3% |
| Pre-tax Income | $33.8M | +221.1% | +207.3% |
| Income Tax | $7.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $262.6M | +20.6% | +81.1% |
| Accounts Receivable | $252.6M | +11.9% | +28.6% |
| Inventory | $146.5M | +5.9% | -1.1% |
| Current Assets | $698.4M | +15.9% | +34.0% |
| Total Assets | $1.41B | +4.9% | +9.4% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $154.9M | — | — |
| Capital Expenditures | $12.6M | — | — |
| Investing Cash Flow | -$32.9M | — | — |
| Financing Cash Flow | -$5.3M | — | — |
| Free Cash Flow | $142.3M | — | — |
| +263.5% |
| +198.0% |
| Net Income | $26.6M | +211.3% | +210.1% |
| EPS (Basic) | $1.19 | +221.6% | +193.7% |
| EPS (Diluted) | $1.13 | +213.9% | +189.0% |
| $270.6M |
| +14.2% |
| +42.4% |
| Long-term Debt | $297.7M | -1.3% | -4.9% |
| Total Liabilities | $902.3M | +2.4% | +5.3% |
| Stockholders' Equity | $505.8M | +15.8% | +24.6% |